Especially in the contact urticaria mouse model, M-MSC-mediated skin lesion improvement (Fig. 8A–C) and peripheral T cell activity limitation recovery were also achieved (Fig. 8D) by TGF-β mAb neutralization. This evidence concerns the gene TGFB1 and urticaria.